ANIMATION

Bavituximab Mechanism of Action (MOA)

Share this animation:

Together with Peregrine, we helped depict the mechanism of action behind Bavituximab, an investigational treatment that helps the body recognize cancer cells. Upregulated expression of phosphatidylserine by cancer cells contributes to their ability to avoid destruction by the immune system. Bavituximab targets phosphatidylserine, thereby encouraging active immune activity in cancerous environments.

Share It:
Contact XVIVO

Client


Peregrine Pharmaceuticals, Inc.

XVIVOs staff of consummate professionals worked seamlessly and flawlessly; adding valuable creative input, maintaining perfect communication, meeting or beating the timeline, and coming in within budget. If you want the absolute best in the field, look no further. Give Robert Krensel a call right away. Or you can just take your chances.

VP, Associate Creative Director, Revolution Health
Share this animation: